The current composition of vaccines uses so-called “facilitating” antibodies that promote infection by the SARS-CoV-2 virus that causes Covid-19 disease. Explanations with Dr. Jean-Marc Sabatier, Research Director at CNRS and PhD in Cell Biology and Microbiology, affiliated with the Institute of NeuroPhysiopathology (INP), at the University of Aix-Marseille.